FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 29, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 29, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 43.3% of total US population have received at least 1 dose
• 30% of total US population are fully vaccinated
• 30% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 38.5%
2. Connecticut: 37.9%
3. Vermont: 36.7%
4. New Mexico: 36.5%
5. South Dakota: 36%
2. Connecticut: 37.9%
3. Vermont: 36.7%
4. New Mexico: 36.5%
5. South Dakota: 36%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 261 274 confirmed cases
• 574 767 deaths
• 574 767 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 738 627
2. Texas: 2 888 909
3. Florida: 2 222 546
4. New York: 2 044 345
5. Illinois: 1 331 751
2. Texas: 2 888 909
3. Florida: 2 222 546
4. New York: 2 044 345
5. Illinois: 1 331 751
Deaths: California has the most deaths due to COVID-19 with 61 636 reported fatalities, followed by New York with 52 208, and Texas with 50 163.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 149 923 201 confirmed cases, 3 155 907 deaths, and 87 085 266 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
Advertisement
Advertisement
Trending on Patient Care Online
1
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
2
Type 2 Diabetes, Genetic Risk Linked to MASLD Cirrhosis Before Age 50
3
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
4
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
5